🔗 Share this article

Grammy-winning R&B singer D’Angelo passed away on October 14 at 51 years old after a private battle with pancreatic malignancy.

“The brilliant light of our family has faded away for us in this life,” his relatives stated. “After a prolonged and brave battle with cancer, we are heartbroken to declare that D’Angelo, known to his fans around the globe as D’Angelo, has been called home.”

D’Angelo left an indelible mark on music with his innovative neo-soul sound and collaborations with high-profile artists.

He released his first record, “Brown Sugar,” in 1995 to immediate acclaim. The album reached the fourth spot on the R&B charts, went platinum soon after, and earned multiple Grammy nominations.

However, it was his sophomore release, “Voodoo,” in 2000 that propelled his artistic journey into the stratosphere. The record premiered at the top spot on each of the R&B charts and the Billboard 200. He received two Grammys: Top R&B Record and Best Male R&B Vocal Performance for “Untitled (How Does It Feel).”

The music video for “Untitled (How Does It Feel)” solidified D’Angelo’s reputation as a sex symbol, albeit a hesitant one, in the public consciousness. The personal depiction featured the singer, famously bare to his midsection, singing straight into the lens.

D’Angelo stepped back from the public eye after releasing Voodoo and openly battled with drugs and alcohol. In 2005, he was part of a severe car crash that left him in grave health.

Over ten years later, his third and final album, “Black Messiah” (2014), confirmed his lasting popularity with a further top chart entry on the R&B chart and a Grammy for Best R&B Album.

Again, in his own mysterious way, D’Angelo made only a few public appearances in the following years.

The musician was announced as a headliner for the 2025 Roots Picnic festival, but his appearance was canceled, due to an “unforeseen medical delay.”

Although details are sparse about D’Angelo’s well-being in the weeks leading up to his death, he had apparently been in the hospital for an extended period and in hospice for a fortnight.

D’Angelo’s passing is a stark reminder of the devastating effects of pancreatic cancer, one of the most deadly and hardest to prevent types of the illness, on a gifted artist whose existence was ended too soon.

“We are saddened that he can only provide dear memories with his family, but we are forever thankful for the heritage of extraordinarily moving music he leaves behind,” his kin expressed.

Pancreatic Malignancy: Deadly and Difficult to Avoid

Pancreatic malignancy impacts the digestive organ, a tiny gland that produces insulin and plays an essential role in breaking down food, among additional roles. The size and location of the organ in the human system make it more challenging to detect cancer.

Although this cancer accounts for only approximately three percent of cancer diagnoses each year in the United States, it is causes seven percent of cancer deaths.

Almost seventy thousand people will be diagnosed with this condition and roughly 52,000 will succumb to the illness in 2025.

“Pancreatic cancer is one of the most lethal diseases, with an aggressive tumor and poor prognosis. We have limited and poor therapies, and a smaller window to make a significant difference on the lives of patients,” said a medical oncologist.

Since this disease rarely causes initial signs, it’s frequently diagnosed only after the condition is advanced. Even when a patient has indicators they are often vague and may be mistaken for a number of common illnesses.

“As of yet, there is no effective method to identify this malignancy in the early stages, except for listening to your body and consulting your physician if there are new or unusual symptoms,” explained a medical director.

Common symptoms of this disease include:

• abdominal or lower back pain
• reduced body mass
• jaundice
• loss of appetite
• brownish urine
• pale or fatty bowel movements
• loose stools
• increased appetite or thirst
• feeling sick

At age 51, D’Angelo’s demise is an outlier, as pancreatic cancer is most common in adults in the sixty-five to seventy-five range. However, numerous malignancies, such as this type, have become more common among younger people.

“This disease diagnosed prior to fifty is deemed uncommon, yet alarmingly, doctors are noticing a rising count of younger individuals suffering from this condition,” said a expert.

Genetic Background Affects Disease Probability

In the absence of reliable screening tools for this malignancy, experts stressed the importance of knowing your family’s cancer history. Some contributing elements, such as smoking and obesity also have an influence in the development of pancreatic cancer.

African Americans have the highest incidence of this malignancy in the U.S. and are most likely to be diagnosed with inoperable cancer.

“The initial action toward reducing one’s risk of this condition is assessing personal risk factors. People should review their genetic background, genetic background, and medical conditions, such as diabetes, chronic pancreatitis, or overweight that may raise their susceptibility,” advised a medical professional.

Hereditary elements are associated with as much as 10% of all this malignancy instances. If a relative in your household has had pancreatic cancer, you may want to consider genetic testing.

“For people with a relative’s background of pancreatic cancer or those carrying elevated risk DNA changes, checking may involve sophisticated scans such as magnetic resonance imaging (MRI) or internal ultrasound to find early changes in the pancreas,” he explained.

For those looking to reduce their risk, habit adjustments may have an effect. The best step you can take to lower your risk of pancreatic cancer is to quit smoking, and if you don’t smoke, avoid exposure altogether.

Excessive alcohol consumption is associated with pancreatitis, a risk factor for this malignancy, so reducing or abstaining from alcohol may assist reduce your risk.

Managing your weight or losing weight may also help reduce your risk. Individuals with obesity are twenty percent more prone to develop pancreatic cancer. This malignancy also is more frequent in people with diabetes, and weight loss can also reduce the chance of type 2 diabetes.

Despite this disease’s grim outlook, there is reason for optimism.

“We are making progress with treatments and newer combination chemotherapy. There are developing targeted therapies that are already showing results,” remarked a expert.

For many people, however, education about this rare but {dev